New Jersey, August 08, 2022 – Freyr announces the appointment of Venkat Luckyreddy as the new Chief Information Security Officer (CISO).
With over 20 years of experience in cybersecurity, Venkat has demonstrated extensive working experience in various challenging and complex environments (Startups, Big Four Audit/Consulting Firm, Fortune 500 – Technology Service Provider, Fortune 100 – Industry Companies, etc.). Prior to Freyr, he was with Bristol Myers Squibb as a key member of their cybersecurity risk function. During this tenure, he has successfully enabled the realization of many complex business and technology initiatives with his cybersecurity expertise.
As a perpetual learner, his cybersecurity expertise ranges among Risk Management, Cloud Security & Architecture, Compliance Management, and Controls Review, which are integral for the Life Sciences and Healthcare industries. He believes Cybersecurity not only enables to secure, support, and scale of the business but also creates value for the business, and it can tilt the timescale in Life Sciences & Healthcare Industry in its pursuit of health equity for patients.
“In this digital age, cybersecurity and data protection are key to the success of any business. We are pleased to have Venkat as he brings two decades of relevant experience that can be put to the best use in the ever-changing life sciences domain,” said Suren Dheenadayalan, CEO at Freyr. “This move further reinforces our commitment towards a secured environment giving utmost value and protection to the customer’s data. We believe that his proven industry specialization across Life Sciences & Pharmaceuticals will win customers’ confidence for us,” Suren added.
Freyr is one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry, supporting Large, Medium, and Small size global Life Sciences companies (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics) in their entire Regulatory value-chain, ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post-approval/Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions. Freyr is also expanding its footprints into other key areas like Pharmacovigilance.
Headquartered in New Jersey, USA, Freyr has regional offices across the UK, Germany, France, Switzerland, UAE, Canada, Mexico, Singapore, Malaysia, South Africa, Slovenia, Sri Lanka, Australia, Poland, China, Japan and a Global Delivery Center in Hyderabad, India.
- 1000+ global clients and growing
- 1300+ in-house Regulatory experts
- 950+ in-country Regulatory affiliates across 120+ countries
- ISO 9001 Certified for strong process and quality management
- ISO 27001 Certified for information security management, state-of-the-art infrastructure